TY  - CONF

T1  - Frequent intermittent low-dose therapy accentuates the antitumour activity of the bisphosphonate risedronate in vivo

JO  - BONE

PY  - 2010/07/01

AU  - Stresing V

AU  - Deux B

AU  - Mathevet P

AU  - Ebetino FH

AU  - Clezardin P

ED  - 

DO  - DOI: 10.1016/j.bone.2010.01.303

VL  - 47

SP  - S322

EP  - S322

Y2  - 2025/05/20

ER  -